| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |